The American Heart Association (AHA), the world’s top voluntary health organization against cardiovascular disease, recently released recommendations to improve standards of high-quality, timely CPR from dispatchers.
Leaders with the Cure Alzheimer’s Fund, a nonprofit organization, recently decided to invest over $6 million in research for 2016 alone, funding scientists to further understand Alzheimer’s and create effective therapies.
The American Heart Association (AHA) recently partnered with the White House to hold a briefing about cardiovascular health within the U.S., inviting volunteers to attend the event in Washington, D.C., on Sept. 9.
The American Heart Association (AHA) recently released a scientific statement saying that various sleep disorders and sleep patterns could be connected to risk factors for developing cardiovascular health problems.
The latest American Heart Association (AHA) 'Rapid Access Journal Report' stated that smoking has long-lasting, broad effects on human DNA, helping scientists to better understand diseases connected to smoking.
Leaders of the National Health Council recently applauded the FDA for adding new patient engagement goals, which are now part of the performance goals letter that reauthorizes the Prescription Drug User Fee Act.
U.S. Sen. Lamar Alexander (R-TN) recently stated that the new U.S. Food and Drug Administration (FDA) proposal could stop over 60,000 lab-developed tests that many Americans need to receive lifesaving treatments and cures.
American Airlines recently agreed to a multi-year financial commitment to the Answer ALS research project, investing $1 million in the most comprehensive genetic, clinical, biochemical and molecular assessment of ALS.
Allele Biotechnology and Pharmaceuticals recently received funds from the National Institute on Aging, a branch of the National Institutes of Health (NIH), to create a novel antibody therapy to treat Alzheimer’s.